Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 38% ± 22% | |
GABAergic neuron | 7 studies | 38% ± 21% | |
pancreatic A cell | 4 studies | 82% ± 14% | |
type B pancreatic cell | 4 studies | 83% ± 12% | |
neuron | 4 studies | 27% ± 5% | |
retinal ganglion cell | 4 studies | 70% ± 21% | |
pancreatic D cell | 3 studies | 89% ± 7% | |
amacrine cell | 3 studies | 25% ± 5% | |
retina horizontal cell | 3 studies | 26% ± 8% | |
interneuron | 3 studies | 43% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 9965.85 | 2462 / 2642 | 96% | 33.32 | 678 / 705 |
pancreas | 71% | 1565.35 | 233 / 328 | 87% | 50.19 | 154 / 178 |
adrenal gland | 29% | 1319.04 | 75 / 258 | 77% | 193.60 | 176 / 230 |
intestine | 23% | 265.57 | 225 / 966 | 19% | 2.95 | 102 / 527 |
stomach | 19% | 230.28 | 69 / 359 | 20% | 0.83 | 56 / 286 |
skin | 14% | 206.08 | 248 / 1809 | 19% | 2.32 | 88 / 472 |
lung | 0% | 1.39 | 1 / 578 | 24% | 1.41 | 276 / 1155 |
kidney | 0% | 0 | 0 / 89 | 21% | 2.02 | 186 / 901 |
breast | 0% | 6.90 | 2 / 459 | 19% | 0.82 | 207 / 1118 |
bladder | 0% | 0 | 0 / 21 | 16% | 0.85 | 80 / 504 |
ovary | 0% | 0 | 0 / 180 | 16% | 0.43 | 67 / 430 |
uterus | 0% | 0 | 0 / 170 | 15% | 1.33 | 69 / 459 |
esophagus | 2% | 19.86 | 31 / 1445 | 10% | 0.53 | 19 / 183 |
eye | 0% | 0 | 0 / 0 | 8% | 0.82 | 6 / 80 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.17 | 3 / 45 |
prostate | 0% | 4.49 | 1 / 245 | 3% | 0.07 | 17 / 502 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
thymus | 1% | 10.94 | 5 / 653 | 2% | 0.05 | 10 / 605 |
liver | 0% | 3.32 | 1 / 226 | 1% | 0.09 | 5 / 406 |
heart | 0% | 2.76 | 3 / 861 | 0% | 0 | 0 / 0 |
adipose | 0% | 3.79 | 2 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 1.55 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001553 | Biological process | luteinization |
GO_1990502 | Biological process | dense core granule maturation |
GO_0035773 | Biological process | insulin secretion involved in cellular response to glucose stimulus |
GO_0051046 | Biological process | regulation of secretion |
GO_0000302 | Biological process | response to reactive oxygen species |
GO_0030073 | Biological process | insulin secretion |
GO_1904692 | Biological process | positive regulation of type B pancreatic cell proliferation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0043679 | Cellular component | axon terminus |
GO_0005634 | Cellular component | nucleus |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0043025 | Cellular component | neuronal cell body |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0045202 | Cellular component | synapse |
GO_0030141 | Cellular component | secretory granule |
GO_0030658 | Cellular component | transport vesicle membrane |
GO_0005768 | Cellular component | endosome |
GO_0008134 | Molecular function | transcription factor binding |
GO_0030507 | Molecular function | spectrin binding |
GO_0005515 | Molecular function | protein binding |
GO_0044389 | Molecular function | ubiquitin-like protein ligase binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPRN |
Protein name | PTPRN protein Protein tyrosine phosphatase receptor type N transcript variant 1 Protein tyrosine phosphatase, receptor type, N Receptor-type tyrosine-protein phosphatase-like N (R-PTP-N) (Islet cell antigen 512) (ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment (ICA512-NTF); ICA512-transmembrane fragment (ICA512-TMF); ICA512-cleaved cytosolic fragment (ICA512-CCF)] Protein tyrosine phosphatase receptor type N |
Synonyms | ICA512 hCG_15565 ICA3 |
Description | FUNCTION: Plays a role in vesicle-mediated secretory processes . Required for normal accumulation of secretory vesicles in hippocampus, pituitary and pancreatic islets (By similarity). Required for the accumulation of normal levels of insulin-containing vesicles and preventing their degradation . Plays a role in insulin secretion in response to glucose stimuli . Required for normal accumulation of the neurotransmitters norepinephrine, dopamine and serotonin in the brain (By similarity). In females, but not in males, required for normal accumulation and secretion of pituitary hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (By similarity). Required to maintain normal levels of renin expression and renin release (By similarity). Seems to lack intrinsic enzyme activity (By similarity). May regulate catalytic active protein-tyrosine phosphatases such as PTPRA through dimerization (By similarity). .; FUNCTION: [ICA512-transmembrane fragment]: ICA512-TMF regulates dynamics and exocytosis of insulin secretory granules (SGs); binding of ICA512-TMF to SNTB2/beta-2-syntrophin is proposed to restrain SGs mobility and exocytosis by tethering them to the actin cytoskeleton depending on UTRN; the function is inhibited by cytoplasmic ICA512-CFF dimerizing with ICA512-TMF and displacing SNTB2. .; FUNCTION: [ICA512-cleaved cytosolic fragment]: ICA512-CCF translocated to the nucleus promotes expression of insulin and other granule-related genes; the function implicates binding to and regulating activity of STAT5B probably by preventing its dephosphorylation and potentially by inducing its sumoylation by recruiting PIAS4 . Enhances pancreatic beta-cell proliferation by converging with signaling by STAT5B and STAT3 . ICA512-CCF located in the cytoplasm regulates dynamics and exocytosis of insulin secretory granules (SGs) by dimerizing with ICA512-TMF and displacing SNTB2 thus enhancing SGs mobility and exocytosis . . |
Accessions | ENST00000409251.7 [Q16849-2] H7C0U9 ENST00000440552.5 ENST00000442029.5 C9JR27 A0A4Y5WWT4 ENST00000606213.5 Q96IA0 ENST00000295718.7 [Q16849-1] ENST00000423636.6 [Q16849-3] ENST00000412847.5 Q7KZS4 C9JCQ0 Q16849 U3KQ66 C9JJL7 ENST00000451506.5 A0A1B0GX26 C9J392 ENST00000443981.5 ENST00000446182.5 |